Vol. 45 No. 2 (2023): Experimental Oncology

Reviews

  • FEATURES OF BREAST CANCER IN PATIENTS OF YOUNG AGE: SEARCH FOR DIAGNOSIS OPTIMIZATION AND PERSONALIZED TREATMENT

    V. CHEKHUN, О. MARTYNYUK, Ye. LUKIANOVA, O. MUSHII, T. ZADVORNYI, N. LUKIANOVA
    139-150
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.139
  • EVALUATION OF CURRENT FACTORS OF RADIATION-ASSOCIATED CARCINOGENESIS

    E.A. Domina, O.L. Kopylenko, V.F. Chekhun
    151-160
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.151

Original contributions

  • CLINICAL SIGNIFICANCE OF BRCA1 GENE SEQUENCING AND ITS PROMOTER METHYLATION TESTING IN THE SEARCH STRATEGY FOR THERAPEUTIC TARGETS IN BREAST CANCER TREATMENT

    L. Fishchuk, O. Lobanova, Z. Rossokha, V. Cheshuk, R. Vereshchako, Yu. Vagyn, V. Kashuba, V. Vershyhora, O. Popova, N. Levkovich, O. Zemlianska, O. Ievseienkova, S. Podolska, N. Gorovenko
    161-169
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.161
  • PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS

    S. Tabassum, F. Munir, A.A. Al Awadh, Z. Anwar
    170-179
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.170
  • ASSOCIATION OF miRNA EXPRESSION PATTERN WITH OUTCOME OF LETROZOLE THERAPY IN BREAST CANCER PATIENTS

    O. Pridko, T. Borikun, O. Rossylna, A.V. Rusyn
    180-186
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.180
  • THE STUDY OF PROGNOSTIC VALUE OF microRNAs (miR-10b AND -155) AND CDKN2A/P16INK4A IN ORAL SQUAMOUS CELL CARCINOMA

    О. Kravets, O. Burtyn, T. Borikun, O. Rossylna
    187-194
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.187
  • ABERRANT METHYLATION OF CANCER-RELATED GENES IN VIETNAMESE BREAST CANCER PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES

    Linh Dieu Vuong, Quang Ngoc Nguyen
    195-202
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.195
  • EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & −191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA

    Wani Zahoor, Arshad A. Pandith, Syed Nisar, Iqbal Qasim, Menka Surana, Farooq A. Ganie, Usma Manzoor, Sajad H. Arif, Shayaq Ul Abeer Rasool, Adil Lateef, Parveen Shah, Rashid A. Bhat
    203-210
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.203
  • EFFECT OF ANTI-TSLPR MONOCLONAL ANTIBODY ON VIABILITY, PROAPOPTOTIC GENES EXPRESSION, AND PRODUCTION OF PRO-INFLAMMATORY CYTOKINES IN MCF-7 AND A549 CELLS

    Alyaa Rakha, Roba M. Talaat, Eman A. El-maadawy, Adel A. Gurguis
    211-219
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.211
  • RED RICE BRAN EXTRACT SUPPRESSES COLON CANCER CELLS VIA APOPTOSIS INDUCTION/CELL CYCLE ARREST AND EXERTS ANTIMUTAGENIC ACTIVITY

    Ratsada Praphasawat, Sarawoot Palipoch, Prasit Suwannalert, Witchuda Payuhakrit, Paween Kunsorn, Sarunya Laovitthayanggoon, Sinittra Thakaew, Narongsuk Munkong, Warangkhana Klajing
    220-230
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.220
  • PREDICTIVE POWER OF OXIDATIVE STRESS BIOMARKERS IN RECURRENCE AND SURVIVAL IN ADVANCED CERVICAL CANCER

    Marija Jelic, Aljosa Mandic, Slobodan Maricic, Biljana Bozin, Nebojsa Kladar, Jan Sudji, Branislava Srdjenovic Conic
    231-241
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.231
  • EFFECT OF LACTATE DEHYDROGENASE INHIBITION BY OXAMATE ON LEWIS LUNG CARCINOMA CELLS WITH DIFFERENT METASTATIC POTENTIAL

    D.L. Kolesnik, I.V. Prokhorova, O.N. Pyaskovskaya, G.I. Solyanik
    242-251
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.242
  • PREVENTION OF PATHOLOGICAL EFFECT OF ISCHEMIA-REPERFUSION IN LIVER RESECTION BY SEVOFLURANE PRECONDITIONING

    I.I. Lisnyy, K.A. Zakalska, A.A. Burlaka, S.A. Lysykh, O.V. Efimenko
    252-262
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.252

Case report

  • SYNCHRONOUS DIAGNOSIS OF TESTICULAR AND THYROID CANCER IN A YOUNG MALE

    N. Tsoukalas, M. Kiakou, M. Tolia, M. Galanopoulos, K. Tsapakidis, E. Arvanitou, N. Charalambakis, V. Tountziaris, M. Nikolaou, Ch. Christofyllakis
    263-268
    DOI: https://doi.org/10.15407/exp-oncology.2023.02.263